Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) appears in 179 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 31 Mar, 2026 | 17,687,772 | 0 | 0.00% | $63,322,224.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 7,834,795 | -71,276 | -0.90% | $28,048,565.00 |
| Citigroup Inc | 31 Mar, 2026 | 5,107,708 | -138,641 | -2.64% | $18,285,595.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 4,690,215 | 4,690,215 | 0.00% | $16,790,970.00 |
| State Street Corp | 31 Mar, 2026 | 4,485,989 | 2,785,358 | 163.78% | $16,059,841.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 3,775,736 | 3,775,736 | 0.00% | $13,517,135.00 |
| MAVERICK CAPITAL LTD | 31 Mar, 2026 | 3,567,372 | 1,054,262 | 41.95% | $12,771,192.00 |
| Newtyn Management, LLC | 31 Mar, 2026 | 3,165,900 | 515,900 | 19.47% | $11,333,922.00 |
| Nuveen, LLC | 31 Mar, 2026 | 3,128,753 | 2,970,741 | 1,880.07% | $11,200,936.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 3,118,124 | 1,333,203 | 74.69% | $11,162,884.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 3,069,930 | 2,366,402 | 336.36% | $10,990,350.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 3,038,715 | 3,012,368 | 11,433.44% | $10,878,600.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 2,189,256 | 68,987 | 3.25% | $7,839,361.00 |
| D. E. Shaw & Co., Inc. | 31 Mar, 2026 | 2,169,625 | -470,893 | -17.83% | $7,767,257.00 |
| Monaco Asset Management SAM | 31 Mar, 2026 | 2,058,303 | -928,993 | -31.10% | $7,368,725.00 |
| Morgan Stanley | 31 Mar, 2026 | 2,020,108 | -1,921,269 | -48.75% | $7,231,988.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 1,721,116 | -152,072 | -8.12% | $6,161,594.00 |
| UBS Group AG | 31 Mar, 2026 | 1,298,173 | 1,146,741 | 757.26% | $4,647,459.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 1,097,623 | -1,034,306 | -48.52% | $3,929,490.00 |
| Federated Hermes, Inc. | 31 Mar, 2026 | 1,023,747 | 142,498 | 16.17% | $3,665,014.00 |